When Canadian Femtech companies begin thinking about international expansion, one market almost always dominates the conversation: the United States.
And for good reason. The U.S. offers scale, capital, and a well-established innovation ecosystem. But looking exclusively across the border means overlooking another rapidly developing, high-impact opportunity: Latin America.
What does it take to move a promising women’s health innovation from Canadian labs to emerging global markets?
A recent Femtech Canada roundtable brought together Yesica Mendez, founder of Femtech LATAM, and Mayra Hurtado, founder of FemTech Mexico, to explore what is happening across the region and what Canadian femtech innovators could learn from it.
A growing ecosystem with significant gaps
According to the latest Femtech LATAM Landscape, the region’s innovation footprint is expanding at a remarkable pace—now mapping 110 startups, up from 70 in its initial iteration. Geographically, Brazil continues to lead the region in total innovation volume and startup density, followed closely by robust hubs in Argentina, Mexico, Colombia, Chile, and Uruguay. However, while early regional innovation has concentrated heavily in reproductive health, contraception, and menstrual wellness, severe vertical imbalances persist, leaving critical gaps across menopause care, oncology, cancer prevention, and mental health.
These unaddressed spaces present an exceptional opening for Canadian companies grounded in evidence generation and clinical research. However, scaling across Latin America requires a deep appreciation for local realities. Because access to smartphones, primary care, and basic sanitary products varies significantly between socioeconomic groups, effective solutions must be engineered with affordability, local accessibility, and cultural context in mind.
As Yesica explained, these gaps themselves can become opportunities for innovation. “We see this gap as an opportunity,” she said, pointing to challenges such as digital access barriers and menstrual poverty that can be less visible in European and North American markets. For companies looking to enter the region, she emphasized that building for Latin America means designing solutions that are inclusive and responsive to the realities of the communities they aim to serve.
Mexico: More than a market
Mexico represents a standout opportunity for healthtech founders looking to scale efficiently. Mexico’s female population alone is four times the total population of Canada, yet its native startup landscape remains disproportionately small. This striking market imbalance creates an ideal environment for soft-landing Canadian healthtech solutions designed to address unmet clinical needs.
Beyond direct commercialization, Mexico offers a powerful operational launchpad for Canadian innovators. As the top exporter of medical devices to the U.S., Mexico provides established, cost-effective infrastructure for prototyping, regulatory navigation, and full-scale manufacturing—an ideal fit for hardware and hybrid Femtech solutions. Additionally, high patient volumes across major university health networks enable companies to conduct diverse clinical trials and build strong medical evidence at a fraction of North American costs. Ultimately, Mexico serves as both a high-demand end market and a scalable engine for R&D, clinical validation, and global export.
As Mayra explained, “Mexico has the qualified talent, research capacity, and manufacturing power, but we lacked the integrated ecosystem to tie it together. Now, through Femtech Mexico, we are building the pathways to soft-land foreign startups and help them build, test, and export.”
International expansion requires local knowledge
The conversation also highlighted an important lesson: entering a new market is about more than understanding regulations and market size.
Healthcare systems, clinical practices, data requirements and consumer behaviours can differ significantly between countries. In Latin America, even the way healthcare professionals and patients communicate can look different. As one participant shared, WhatsApp plays a much more prominent role in healthcare communication than many Canadian companies may be accustomed to.
Local relationships therefore matter.
Organizations such as Femtech LATAM and FemTech Mexico can help connect innovators with the people and infrastructure needed to navigate these differences.
Looking beyond borders
The opportunity for Canadian Femtech is not simply to export products south. It is to build stronger connections between ecosystems.
Canada brings its own strengths in research, innovation and entrepreneurship. Latin America brings large and diverse populations, emerging Femtech ecosystems, research opportunities and established manufacturing capabilities.
Connecting these strengths could create new pathways for women’s health innovation, across markets, healthcare systems and borders.
The future of Femtech will not be built by individual ecosystems working in isolation. It will be built by connecting them.